Express Scripts-Medco Specialty Pharmacy Combination Is Key To Merger, CEO Affirms
This article was originally published in The Pink Sheet Daily
Executive Summary
Express Scripts would be unwilling to proceed with merger with Medco if FTC says the firm’s specialty drug division must be spun off, CEO George Paz tells Senate subcommittee.
You may also be interested in...
Express Scripts-Medco Merger Closes With No Divestitures Needed
The FTC voted in a split 3-1 vote to close its investigation and allow Express Scripts’ $29.1 billion acquisition of rival PBM Medco to proceed.
Express Scripts/Medco Merger Faces Longer Odds After FTC's Second Request
Following the Federal Trade Commission’s second request for additional information about Express Scripts Inc.'s proposed acquisition of Medco Health Solutions Inc., it is now statistically likely that the deal will be blocked or subject to a divestiture.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.